COVID-19 and immunosuppressive therapy in dermatology

被引：6

作者：

Schwartz, Robert A. ^{[1
]}

Pradhan, Swetalina ^{[2
]}

Murrell, Dedee F. ^{[3
]}

Jafferany, Mohammad ^{[4
]}

Olisova, Olga Y. ^{[5
]}

Lomonosov, Konstantin M. ^{[5
]}

Lotti, Torello ^{[5
,6
]}

Goldust, Mohamad ^{[7
,8
]}

机构：

[1] Rutgers New Jersey Med Sch, Dept Dermatol, Newark, NJ USA

[2] All India Inst Med Sci, Dept Dermatol & Venereol, Patna, Bihar, India

[3] Univ New South Wales, St George Hosp, Dept Dermatol, Fac Med, Sydney, NSW, Australia

[4] Cent Michigan Univ, Coll Med, Saginaw, MI USA

[5] IM Sechenov First Moscow State Med Univ, Dept Dermatol & Venereol, Moscow, Russia

[6] Univ Studies Guglielmo Marconi, Dept Dermatol, Rome, Italy

[7] Univ Studies Guglielmo Marconi, Rome, Italy

[8] Univ Hosp Basel, Dept Dermatol, Basel, Switzerland

来源：

DERMATOLOGIC THERAPY | 2020年 / 33卷 / 06期

关键词：

COVID; 19; dermatology; immunosuppressive therapy; ATOPIC-DERMATITIS; DIAGNOSIS;

D O I：

10.1111/dth.14140

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Coronavirus 2019 (COVID 19) was first detected in December 2019 in China. It has become a pandemic. With concern about therapies that may decrease immunity and enhance the severity of an individual's COVID-19 infection, leading to a possibly fatal outcome, use of immunosuppressants has become an important concern. This work focuses on management of various skin diseases individuals lacking immunity to COVID-19 but requiring a systemic immunosuppressant, keeping in view the challenge of the COVID 19 pandemic and that our knowledge of this virus and its effects on the immune system are incomplete including knowledge as to an individual's immunity after COVID-19 infection.

引用

页数：6

共 50 条

[1] Immunosuppressive and immunomodulatory therapies in dermatology and coronavirus disease 2019 (COVID-19)
Mansouri, Parvin
Farshi, Susan
Nikkhah, Nahid
Nobari, Niloufar Najar
Chalangari, Reza
Nilforoushzadeh, Mohammad Ali
CLINICS IN DERMATOLOGY, 2021, 39 (03) : 517 - 520
[2] COVID-19 and dermatology
Gul, Ulker
TURKISH JOURNAL OF MEDICAL SCIENCES, 2020, 50 (08) : 1751 - 1759
[3] Dermatology and COVID-19
Shinkai, Kanade
Bruckner, Anna L.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 324 (12): : 1133 - 1134
[4] COVID-19 and Dermatology
Das, Anupam
INDIAN JOURNAL OF DERMATOLOGY, 2021, 66 (03) : 229 - 230
[5] Immunosuppressive therapy and COVID-19 infection in patients with NMOSD
Choi, Un Wai
Ai, Xiwen
Li, Hongyan
Hao, Yong
Yao, Xiaoying
Guan, Yangtai
IMMUNITY INFLAMMATION AND DISEASE, 2024, 12 (01)
[6] COVID-19: biologic and immunosuppressive therapy in gastroenterology and hepatology
Neurath, Markus F.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2021, 18 (10) : 705 - 715
[7] Covid-19 in kidney transplant recipients with immunosuppressive therapy
Sheikhalipour, Zahra
Faghihdinevari, Masood
Salehi-Pourmehr, Hanieh
Khameneh, Maryam
Vahedi, Leila
CASPIAN JOURNAL OF INTERNAL MEDICINE, 2022, 13 : 161 - 172
[8] The COVID-19 pandemic: implications for patients undergoing immunomodulating or immunosuppressive treatments in dermatology
Markus Reinholz
Lars E. French
Carola Berking
Markus V. Heppt
European Journal of Dermatology, 2020, 30 : 757 - 758
[9] The COVID-19 pandemic: implications for patients undergoing immunomodulating or immunosuppressive treatments in dermatology
Reinholz, Markus
French, Lars E.
Berking, Carola
Heppt, Markus V.
EUROPEAN JOURNAL OF DERMATOLOGY, 2020, 30 (06) : 757 - 758
[10] COVID-19: biologic and immunosuppressive therapy in gastroenterology and hepatology
Markus F. Neurath
Nature Reviews Gastroenterology & Hepatology, 2021, 18 : 705 - 715

← 1 2 3 4 5 →